Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published ...

Dr. Deepak Chopra warns against the brain-related risks of weight-loss drugs, emphasizing their potential to alter metabolism ...

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...

It should go without saying, but evidently, it bears repeating: you can’t tell how healthy someone is just by looking at ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

The link between obesity and depression is known, but GLP-1 medications may benefit those suffering in ways other than weight loss (Getty) A meta-analysis also suggested a reduction in depression ...

THEY are the drugs that have taken 2024 by storm – and now weight loss injections could come with yet more added benefits. So-called skinny jabs – that were initially designed as ...

Newer GLP-1 weight loss drugs, like Wegovy ... nearly 80% of teens seeking treatment for obesity reported symptoms of depression and eating disorders. According to WebMD, mental health experts ...

such as reducing inflammation and depression. These antiobesity drugs could even have a place in cancer care. While there's limited data to support the use of GLP-1 agonists for weight loss in ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

SNRIs are often preferred for treating more severe cases of depression. Common examples include duloxetine, desvenlafaxine ...

Weight-loss drugs have skyrocketed in popularity because of their quick results and use among celebrities and influencers. J.P. Morgan predicts that by 2030, 30 million Americans will use them.